Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-03
1994-10-04
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142358, 514312, 514314, 514397, 544139, 546155, 546156, 546157, 546167, 546278, 5483114, 5483151, 5483154, A61K 31535, A61K 3147, C07D41310, C07D40710
Patent
active
053526872
ABSTRACT:
Substituted phenylacetamides can be prepared by reaction of appropriately substituted phenylacetic acids with imidazoles and subsequent amidation. The substituted phenylacetic acid derivatives can be employed in medicaments for the treatment of high blood pressure and atherosclerosis.
REFERENCES:
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4946841 (1990-08-01), Baader et al.
Upsekhi Khimii, Russian Chemical Reviews, 32, 1 (1963).
Frerman, et al., "Leucine Catabolism during the Differentiation of 3TG3-L1 Cells", 258, 7087-1093 (1983).
Ross, R., The Journal of Cell Biology, vol. 50, 1971, 172-186.
Benoiton, et al., Int. Pept. Prot. Res. 17, 197 (1981).
Sheehan, et al., J. Am. Chem. Soc. 95, 875 (1973).
J. Am. Chem. Soc., Chem. Comm. (2) 167-168 (1966).
Journal of Medicinal Chemistry, vol. 33, No. 5, May 1990, 1312-1329.
S. R. Adapa & C. S. N. Prasad, J. Chem. Soc., Perkin Trans. 1, (9) pp. 1706-1707 (1989).
Beuck Martin
Dressel Jurgen
Fey Peter
Hanko Rudolf
Hubsch Walter
Bayer Aktiengesellschaft
Morris Patricia L.
LandOfFree
Substituted phenylacetamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted phenylacetamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted phenylacetamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581507